Advertisements


NEJM publishes results from phase 2 study of vaccines reducing TB infections

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

VBI Vaccines announces "positive" final Phase 1 study results for VBI-1501

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2018

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow.....»»

Category: topSource: seekingalphaJul 19th, 2018

Viking Therapeutics announces VK5211 Phase 2 study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

Scynexis announces results from Phase 2b study evaluating oral SCY-078

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Celsion announces publication of ThermoDox Phase I clinical study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

PTC Therapeutics announces "positive" results from Translarna Phase II Study 030

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 9th, 2018

After Biogen"s Alzheimer"s Update, Wall Street Reacts

Biogen Inc (NASDAQ: BIIB) and its Japanese partner Eisai disclosed¬†encouraging results from an 18-month Phase 2 study of its Alzheimer's therapy BAN2401. .....»»

Category: blogSource: benzingaJul 6th, 2018

Exelixis says Celestial Phase 3 results published in NEJM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 4th, 2018

Celgene"s Luspatercept Meets Primary Endpoint in the Study

Celgene Corporation (CELG) and Acceleron Pharma Inc. (XLRN) announces top-line results from a phase III, multi.....»»

Category: personnelSource: nytJun 29th, 2018

Edge Therapeutics updates results from Phase 3 Newton 2 study of EG-1962

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 27th, 2018

Amgen reports results from Phase 3 study of ABP 710

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 27th, 2018

Novo Nordisk"s (NVO) Oral Ozempic Positive in Diabetes Study

Novo Nordisk (NVO) announces positive headline results of two phase III studies PIONEER oral formulation of Ozempic (semaglutide) as a treatment for adults with type II diabetes. Novo Nordisk NVO announced positive headline results o.....»»

Category: personnelSource: nytJun 21st, 2018

TG Therapeutics reports updated results from ongoing ublituximab Phase 2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Protagonist Therapeutics announces results from Phase 1 study of PTG-300

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Cerus reports results of SPARC Phase 3 study at EHA meeting

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Allergan (AGN) Presents Positive Data on Glaucoma Candidate

Allergan (AGN) posts positive top-line data from a phase III study on Bimatoprost SR, a biodegradable implant for reducing IOP in patients with open-angle glaucoma or ocular.....»»

Category: worldSource: nytJun 14th, 2018

Alexion to present results from ALXN1210 Phase 3 study at EHA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Galmed up 60% to $11.30 after 52-week results from Phase 2b ARREST study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Galmed reports 52-week results from Phase 2b ARREST study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Pluristem reports "positive" results from Phase II clinical study of PLX-PAD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018